| Literature DB >> 31272496 |
Boonsub Sakboonyarat1, Ram Rangsin2, Anupong Kantiwong3, Mathirut Mungthin3.
Abstract
OBJECTIVES: The objectives of the research were to determine the prevalence and factors associated of uncontrolled blood pressure among Thai hypertensive patients in a nationwide survey.Entities:
Keywords: Associated factors; Nationwide; Prevalence; Thailand; Uncontrolled hypertension
Year: 2019 PMID: 31272496 PMCID: PMC6610935 DOI: 10.1186/s13104-019-4417-7
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Demographic characteristics of the enrolled Thai adults with hypertension
| Variables | n (%) |
|---|---|
| Gender | |
| Female | 40,834 (62.2) |
| Male | 24,833 (37.8) |
| Age (years) (mean ± SD) | 63.9 ± 11.7 |
| 20–29 | 98 (0.1) |
| 30–39 | 1077 (1.6) |
| 40–49 | 6383 (9.7) |
| 50–59 | 16,276 (24.8) |
| 60–69 | 19,966 (30.4) |
| 70–79 | 15,511 (23.6) |
| 80–89 | 5832 (8.9) |
| ≥ 90 | 456 (0.7) |
| Region, n (%) | |
| Northeast | 14,864 (22.6) |
| Northern | 18,032 (27.5) |
| Central | 23,104 (35.2) |
| Southern | 9667 (14.7) |
| Hospital level | |
| First level | 45,541 (69.4) |
| Middle level | 15,030 (22.9) |
| Standard/Advance level | 5096 (7.8) |
| Healthcare coverage | |
| Universal coverage scheme | 48,747 (74.2) |
| Government officer | 13,181 (20.1) |
| Social security scheme | 2931 (4.5) |
| Others | 808 (1.2) |
| Occupations | |
| Unemployed/retired | 22,438 (34.2) |
| Agriculturist | 3346 (5.1) |
| Private business | 22,649 (34.5) |
| Officer | 3820 (5.8) |
| Others | 13,414 (20.4) |
| Comorbidity | |
| Dyslipidemia | 41,171 (62.7) |
| Diabetes mellitus | 8628 (13.1) |
| Gout | 5083 (7.7) |
| Smoking | |
| Never | 50,733 (82.6) |
| Ex-smoker | 7624 (12.4) |
| Current smoker | 3035 (4.9) |
| Duration of hypertension (years) (mean ± SD) | 6.5 ± 4.1 |
| Blood pressure (mmHg) | |
| SBP (mean ± SD) | 132.6 ± 15.2 |
| DBP (mean ± SD) | 75.9 ± 10.6 |
| Waist circumference (cm) | 86.3 ± 10.8 |
| BMI (kg/m2) (mean ± SD) | 24.9 ± 4.7 |
| < 25 | 34,137 (54.1) |
| 25–29.99 | 20,797 (33) |
| 30–34.99 | 6386 (10.1) |
| ≥ 35 | 1751 (2.8) |
| Biochemical measurements (mean ± SD) | |
| Serum uric acid (mg/dL) | 6.1 ± 1.8 |
| TC (mg/dL) | 193.7 ± 44.7 |
| TG (mg/dL) | 150.9 ± 89.2 |
| HDL (mg/dL) | 50.7 ± 15.6 |
| LDL (mg/dL) | 115.1 ± 36.8 |
| Estimated GFR (mL/min/1.73 m2) | 71 ± 23.6 |
| ≥ 90 | 13,678 (23.7) |
| 60–89 | 25,263 (43.8) |
| 30–59 | 16,418 (28.4) |
| 15–29 | 1649 (2.9) |
| < 15 | 731 (1.3) |
| Number of antihypertensive medications | |
| 0 | 1110 (1.7) |
| 1 | 26,153 (39.8) |
| 2 | 27,175 (41.4) |
| ≥ 3 | 11,229 (17.1) |
SD standard deviation, mmHg millimeter of mercury, SBP systolic blood pressure, DBP diastolic blood pressure, cm centimeter, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, HDL, high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, BMI body mass index, eGFR estimated glomerulus filtration rate
Univariate analysis for factors associated with uncontrolled hypertension among Thai adults with hypertension
| Variables | Normotension | Uncontrolled HT | Crude | 95% CI | |
|---|---|---|---|---|---|
| n (%) | n (%) | Odds ratio | |||
| Gender | |||||
| Female | 31,077 (76.1) | 9757 (23.9) | 1 | ||
| Male | 18,468 (74.4) | 6365 (25.6) | 1.10 | (1.06–1.14) | < 0.001 |
| Age (years) | 64.9 ± 11.4 | 60.7 ± 12.2 | 0.97 | (0.97–0.97) | < 0.001 |
| 20–29 | 48 (49.0) | 50 (51.0) | 1 | ||
| 30–39 | 625 (58.0) | 452 (42.0) | 0.69 | (0.46–1.05) | 0.084 |
| 40–49 | 4064 (63.7) | 2319 (36.3) | 0.55 | (0.37–0.82) | 0.003 |
| 50–59 | 10,811 (66.4) | 5465 (33.6) | 0.49 | (0.33–0.72) | < 0.001 |
| 60–69 | 16,251 (81.4) | 3715 (18.6) | 0.22 | (0.15–0.33) | < 0.001 |
| 70–79 | 12,613 (81.3) | 2898 (18.7) | 0.22 | (0.15–0.33) | < 0.001 |
| 80–89 | 4697 (80.5) | 1135 (19.5) | 0.23 | (0.16–0.35) | < 0.001 |
| ≥ 90 | 384 (84.2) | 72 (15.8) | 0.18 | (0.11–0.29) | < 0.001 |
| Region | |||||
| Northeast | 11,813 (79.5) | 3051 (20.5) | 1 | ||
| Northern | 13,717 (76.1) | 4315 (23.9) | 1.22 | (1.16–1.28) | < 0.001 |
| Central | 17,101 (74.0) | 6003 (26.0) | 1.36 | (1.29–1.43) | < 0.001 |
| Southern | 6914 (71.5) | 2753 (28.5) | 1.54 | (1.45–1.64) | < 0.001 |
| Hospital level | |||||
| First level | 35,160 (77.2) | 10,381 (22.8) | 1 | ||
| Middle level | 10,668 (71.0) | 4362 (29.0) | 1.39 | (1.33–1.44) | < 0.001 |
| Standard/advance level | 3717 (72.9) | 1379 (27.1) | 1.26 | (1.18–1.34) | < 0.001 |
| Healthcare coverage | |||||
| Universal coverage scheme | 36,881 (75.7) | 11,866 (24.3) | 1 | ||
| Government officer | 10,193 (77.3) | 2988 (22.7) | 0.91 | (0.87–0.95) | < 0.001 |
| Social security scheme | 1903 (64.9) | 1028 (35.1) | 1.68 | (1.55–1.82) | < 0.001 |
| Others | 568 (70.3) | 240 (29.7) | 1.31 | (1.13–1.53) | < 0.001 |
| Occupations | |||||
| Unemployed/retired | 17,809 (79.4) | 4629 (20.6) | 1 | ||
| Agriculturist | 2387 (71.3) | 959 (28.7) | 1.55 | (1.43–1.68) | < 0.001 |
| Private business | 17,266 (76.2) | 5383 (23.8) | 1.20 | (1.15–1.25) | < 0.001 |
| Officer | 2706 (70.8) | 1114 (29.2) | 1.58 | (1.47–1.71) | < 0.001 |
| Others | 9377 (69.9) | 4037 (30.1) | 1.66 | (1.58–1.74) | < 0.001 |
| Dyslipidemia | |||||
| No | 18,345 (74.9) | 6151 (25.1) | 1 | ||
| Yes | 31,200 (75.8) | 9971 (24.2) | 0.95 | (0.92–0.99) | 0.010 |
| Diabetes mellitus | |||||
| No | 43,311 (75.9) | 13,728 (24.1) | 1 | ||
| Yes | 6234 (72.3) | 2394 (27.7) | 1.21 | (1.15–1.28) | < 0.001 |
| Gout | |||||
| No | 45,755 (75.5) | 14,829 (24.5) | 1 | ||
| Yes | 3790 (74.6) | 1293 (25.4) | 1.05 | (0.99–1.12) | 0.126 |
| Smoking | |||||
| Never | 38,552 (76.0) | 12,181 (24.0) | 1 | ||
| Ex-smoker | 5801 (76.1) | 1823 (23.9) | 0.99 | (0.94–1.05) | 0.851 |
| Current smoker | 2202 (72.6) | 833 (27.4) | 1.20 | (1.10–1.30) | < 0.001 |
| Duration of hypertension (years) | 6.6 ± 4.1 | 6.4 ± 4.0 | 0.99 | (0.98–0.99) | < 0.001 |
| Waist circumference (cm) | 85.8 ± 10.6 | 87.8 ± 11.1 | 1.02 | (1.01–1.02) | < 0.001 |
| BMI (kg/m2) | 24.6 ± 4.5 | 25.9 ± 4.9 | 1.06 | (1.06–1.06) | < 0.001 |
| < 25 | 27,156 (79.6) | 6981 (20.4) | 1 | ||
| 25–29.99 | 15,227 (73.2) | 5570 (26.8) | 1.42 | (1.37–1.48) | < 0.001 |
| 30–34.99 | 4309 (67.5) | 2077 (32.5) | 1.88 | (1.77–1.99) | < 0.001 |
| ≥ 35 | 1048 (59.9) | 703 (40.1) | 2.61 | (2.36–2.88) | < 0.001 |
| Biochemical measurements | |||||
| Serum uric acid (mg/dL) | 6.1 ± 1.8 | 6.2 ± 1.9 | 1.04 | (1.03–1.06) | < 0.001 |
| TC (mg/dL) | 192.3 ± 43.1 | 198.1 ± 49.0 | 1.01 | (1.00–1.01) | < 0.001 |
| TG (mg/dL) | 148.8 ± 87.3 | 157.5 ± 94.6 | 1.01 | (1.00–1.01) | < 0.001 |
| HDL (mg/dL) | 50.7 ± 15.8 | 50.8 ± 15.2 | 1.01 | (1.00–1.01) | 0.467 |
| LDL (mg/dL) | 114.0 ± 36.4 | 118.5 ± 38.1 | 1.01 | (1.00–1.01) | < 0.001 |
| Estimated GFR (mL/min/1.73 m2) | 70.2 ± 23.2 | 73.7 ± 24.7 | 1.01 | (1.00–1.01) | < 0.001 |
| ≥ 90 | 9732 (71.2) | 3946 (28.8) | 1 | ||
| 60–89 | 19,314 (76.5) | 5949 (23.5) | 0.76 | (0.73–0.80) | < 0.001 |
| 30–59 | 12,974 (79.0) | 3444 (21.0) | 0.66 | (0.62–0.69) | < 0.001 |
| 15–29 | 1274 (77.3) | 375 (22.7) | 0.73 | (0.64–0.82) | < 0.001 |
| < 15 | 511 (69.9) | 220 (30.1) | 1.06 | (0.90–1.25) | 0.469 |
| Number of antihypertensive medications | |||||
| 0 | 930 (83.8) | 180 (16.2) | 1 | ||
| 1 | 20,717 (79.2) | 5436 (20.8) | 1.36 | (1.15–1.60) | < 0.001 |
| 2 | 20,148 (74.1) | 7027 (25.9) | 1.80 | (1.53–2.12) | < 0.001 |
| ≥ 3 | 7750 (69.0) | 3479 (31.0) | 2.32 | (1.97–2.73) | < 0.001 |
| Drug classes (monotherapy) | |||||
| ARB | 1953 (76.6) | 595 (23.4) | 1 | ||
| ACEI | 5520 (77.1) | 1644 (22.9) | 0.98 | (0.88–1.09) | 0.678 |
| Anti-adrenergic | 2060 (78.4) | 566 (21.6) | 0.90 | (0.79–1.03) | 0.121 |
| Diuretics | 2697 (80.9) | 635 (19.1) | 0.77 | (0.68–0.88) | < 0.001 |
| CCBs | 8301 (81.2) | 1921 (18.8) | 0.76 | (0.68–0.84) | < 0.001 |
SD standard deviation, mmHg millimeter of mercury, SBP systolic blood pressure, DBP diastolic blood pressure, cm centimeter, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, HDL, high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, BMI body mass index, eGFR estimated glomerulus filtration rate, ARB angiotensin receptor blockers, ACEI angiotensin converting enzyme inhibitors; anti-adrenergic; alpha and beta blockers, CCBs, calcium channel blockers
Multivariate analysis for factors associated with uncontrolled hypertension among Thai adults with hypertension
| Variables | Adjusted odds ratio | 95% CI | |
|---|---|---|---|
| Gender | |||
| Female | 1 | ||
| Male | 1.16 | (1.10–1.20) | < 0.001 |
| Age (years) | 0.97 | (0.97–0.97) | < 0.001 |
| Region | |||
| Northeast | 1 | ||
| Northern | 1.21 | (1.14–1.29) | < 0.001 |
| Central | 1.20 | (1.13–1.28) | < 0.001 |
| Southern | 1.48 | (1.38–1.59) | < 0.001 |
| Hospital level | |||
| First level | 1 | ||
| Middle level | 1.23 | (1.16–1.30) | < 0.001 |
| Standard/advance level | 1.12 | (1.03–1.22) | 0.009 |
| Diabetes mellitus | |||
| No | 1 | ||
| Yes | 1.16 | (1.08–1.23) | < 0.001 |
| Smoking | |||
| Never | 1 | ||
| Ex-smoker | 1.04 | (0.96–1.11) | 0.334 |
| Current smoker | 1.08 | (0.97–1.19) | 0.155 |
| Duration of hypertension (years) | 1.00 | (0.99–1.01) | 0.120 |
| BMI (kg/m2) | |||
| < 25 | 1 | ||
| 25–29.99 | 1.19 | (1.13–1.24) | < 0.001 |
| 30–34.99 | 1.42 | (1.32–1.52) | < 0.001 |
| ≥ 35 | 1.70 | (1.51–1.92) | < 0.001 |
| LDL (mg/dL) | |||
| < 100 | 1 | ||
| > 100 | 1.17 | (1.11–1.22) | < 0.001 |
| Number of antihypertensive medications | |||
| 0 | 1 | ||
| 1 | 1.39 | (1.13–1.70) | 0.002 |
| 2 | 1.80 | (1.47–2.20) | < 0.001 |
| ≥ 3 | 2.32 | (1.89–2.86) | < 0.001 |
LDL low-density lipoprotein cholesterol, BMI body mass index
Adjusted for gender, age, regions, hospital levels, diabetes comorbidity, smoking status, duration of hypertension, body mass index, LDL level and number of antihypertensive medications